Landiao, Jayclark S.
HRN: 19-94-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
AMPICILLIN 250MG (VIAL)
05/03/2022
05/10/2022
IVT
250mg
Q6H
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes